×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [43]
西安交通大学 [25]
中国医学科学院 北... [18]
山东大学 [11]
厦门大学 [8]
暨南大学 [7]
更多...
内容类型
期刊论文 [145]
会议论文 [16]
学位论文 [3]
其他 [1]
发表日期
2022 [1]
2019 [21]
2018 [24]
2017 [18]
2016 [17]
2015 [28]
更多...
学科主题
Biochemist... [2]
Cell Biolo... [2]
Oncology [2]
Research &... [2]
Biochemist... [1]
Endocrinol... [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共165条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D-and 3D-Culture Systems
期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:
Xu, Yipeng
;
Pachnikova, Gabriela
;
Przybilla, Dorothea
;
Schafer, Reinhold
;
Cui, Yingying
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2022/03/28
Prostate Cancer
JQ1
Docetaxel
Combination Treatment
3D Culture Spheroid
A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer
期刊论文
MOLECULAR CANCER, 2019, 卷号: 18
作者:
Gu, Peng
;
Chen, Xu
;
Xie, Ruihui
;
Xie, Weibin
;
Huang, Li
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2019/12/04
Castration resistance prostate Cancer (CRPC)
lncRNA LBCS
Castration resistance
Androgen receptor (AR)
hnRNPK
A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China
期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 卷号: 15, 期号: 3
作者:
He, Dalin
;
Sun, Zhongquan
;
Guo, Jianming
;
Zhang, Zhigen
;
Shan, Yuxi
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2019/12/05
castration-resistant prostate cancer
docetaxel
observational
Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration-sensitive prostate cancer
期刊论文
BJU INTERNATIONAL, 2019, 卷号: 124, 期号: 2
作者:
Yang, Yun-Jie
;
Kong, Yun-Yi
;
Li, Gao-Xiang
;
Wang, Yue
;
Ye, Ding-Wei
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
circulating tumour cells
androgen deprivation therapy
castration-sensitive
prognosis
#ADT
#ProstateCancer
#PCSM
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
期刊论文
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 卷号: 381, 期号: 1
作者:
Zhang, Ke
;
Larsen, Julie S.
;
McCarthy, Sharon
;
Chowdhury, Simon
;
Chi, Kim N.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT)
会议论文
作者:
Woo, H.
;
Fizaz, K.
;
Sulur, G.
;
Tran, N.
;
Fein, L.
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2019/12/05
Management of patients with advanced prostate cancer in the Asia Pacific region: "real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017
期刊论文
BJU INTERNATIONAL, 2019, 卷号: 123, 期号: 1
作者:
Chiong, Edmund
;
Murphy, Declan G.
;
Akaza, Hideyuki
;
Buchan, Nicholas C.
;
Chung, Byung Ha
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
advanced prostate cancer
castration-naive prostate cancer
castration-resistant prostate cancer
high-risk localised prostate cancer
oligometastatic prostate cancer
cost and access to treatment
Clinical activity of abiraterone plus prednisone in docetaxel-naive and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer
期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2019, 卷号: 21, 期号: 2
作者:
Lin, Guo-Wen
;
Li, Gao-Xiang
;
Dai, Bo
;
Ye, Ding-Wei
;
Kong, Yun-Yi
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
abiraterone acetate
castration-resistant prostate cancer
clinical activity
docetaxel-naive
docetaxel-pretreated
Codelivery of miR-4638-5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer
期刊论文
MOLECULAR PHARMACEUTICS, 2019, 卷号: 16, 期号: 1
作者:
Jiang, Wenjun
;
Gao, Yuan
;
Wang, Zhuo
;
Gong, Chunai
;
Hu, Chuling
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/05
codelivery
docetaxel
miR-4638-5p
enhanced effect
castration-resistant prostate cancer
Abiraterone acetate plus prednisone in patients with newly Croatia& diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
期刊论文
LANCET ONCOLOGY, 2019, 卷号: 20, 期号: 5
作者:
Fizazi, Karim
;
NamPhuong Tran
;
Fein, Luis
;
Matsubara, Nobuaki
;
Rodriguez-Antolin, Alfredo
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
©版权所有 ©2017 CSpace - Powered by
CSpace